263 related articles for article (PubMed ID: 24004004)
1. AZT and emodin exhibit synergistic growth-inhibitory effects on K562/ADM cells by inducing S phase cell cycle arrest and suppressing MDR1 mRNA/p-gp protein expression.
Chen P; Liu Y; Sun Y; Chen C; Qi Y; Zhang Y
Pharm Biol; 2013 Dec; 51(12):1586-91. PubMed ID: 24004004
[TBL] [Abstract][Full Text] [Related]
2. Emodin and AZT synergistically inhibit the proliferation and induce the apoptosis of leukemia K562 cells through the EGR1 and the Wnt/β‑catenin pathway.
Ma W; Liu F; Yuan L; Zhao C; Chen C
Oncol Rep; 2020 Jan; 43(1):260-269. PubMed ID: 31746437
[TBL] [Abstract][Full Text] [Related]
3. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide.
Wei HL; Wu YJ; Jing T; Bai DC; Ma LF
Acta Pharmacol Sin; 2003 Aug; 24(8):805-11. PubMed ID: 12904281
[TBL] [Abstract][Full Text] [Related]
4. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
5. [Reversal of multidrug resistance by MDR1 shRNA expression vector in human leukemia K562/A02 cells].
Xiao XB; Xie ZX; Qin Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):422-5. PubMed ID: 17152486
[TBL] [Abstract][Full Text] [Related]
6. Effect of phorbol 12-myristate 13-acetate on function and gene expression of P-glycoprotein in adriamycin-resistant K562/ADM cells.
Li Y; Bi H; Zhong G; Huang L; Li G; Xia Y; Chen X; Huang M
Pharmacology; 2013; 92(3-4):121-30. PubMed ID: 24008321
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562/A02 cells via multiple mechanisms.
Zhao D; Jiang Y; Dong X; Liu Z; Qu B; Zhang Y; Ma N; Han Q
Biomed Pharmacother; 2011 Aug; 65(5):354-8. PubMed ID: 21775093
[TBL] [Abstract][Full Text] [Related]
8. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression.
Pan J; Miao D; Chen L
Chem Biol Interact; 2018 May; 288():32-37. PubMed ID: 29655913
[TBL] [Abstract][Full Text] [Related]
9. [The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
Chang HY; Pan KL; Ma FC; Jiao XY; Zhu HF; Liu JH; Huang Y; Cao YH
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):254-8. PubMed ID: 16875558
[TBL] [Abstract][Full Text] [Related]
10. [siRNA silences mdr1 gene expression and reverses apoptosis resistance of K562/ADM cells line].
Wei HL; Gao LP; Jing T; Zhao HS; Yi J; Sun J; Han J
Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):388-90. PubMed ID: 17939404
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of P-glycoprotein and glutathione S-transferase-pi mediated resistance by fluoxetine in MCF-7/ADM cells.
Zhang Y; Zhou T; Duan J; Xiao Z; Li G; Xu F
Biomed Pharmacother; 2013 Oct; 67(8):757-62. PubMed ID: 23731711
[TBL] [Abstract][Full Text] [Related]
12. [Reversal of mdrl gene-dependent multidrug resistance in multidrug resistance human leukemia cell line K562/ADM using short hairpin RNA expression vectors].
Gan HZ; Zhang GZ; Lu ZX; Pu LS; Yang SJ; Gao S; Zheng DM
Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):383-7. PubMed ID: 17939403
[TBL] [Abstract][Full Text] [Related]
13. HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway.
Wang H; Jia XH; Chen JR; Yi YJ; Wang JY; Li YJ; Xie SY
Int J Oncol; 2016 Dec; 49(6):2529-2537. PubMed ID: 27779650
[TBL] [Abstract][Full Text] [Related]
14. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
Chen JR; Jia XH; Wang H; Yi YJ; Li YJ
Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418
[TBL] [Abstract][Full Text] [Related]
15. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
[TBL] [Abstract][Full Text] [Related]
16. [Arsenic trioxide inhibits P-glycoprotein expression in multidrug-resistant human leukemia K562/ADM cell line that overexpresses mdr-1 gene and enhances their chemotherapeutic sensitivity].
Wei HL; Yao XJ; Li YN; Wang P; Zhao HS; Bai DC; Peng X; Ma LF
Zhonghua Xue Ye Xue Za Zhi; 2003 Jan; 24(1):28-31. PubMed ID: 12679007
[TBL] [Abstract][Full Text] [Related]
17. Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein.
Min H; Niu M; Zhang W; Yan J; Li J; Tan X; Li B; Su M; Di B; Yan F
PLoS One; 2017; 12(11):e0187971. PubMed ID: 29121121
[TBL] [Abstract][Full Text] [Related]
18. Acquired multidrug resistance in human K562/ADM cells is associated with enhanced autophagy.
Cheng J; Chen J; Xie B; Wei HL
Toxicol Mech Methods; 2013 Nov; 23(9):678-83. PubMed ID: 24024664
[TBL] [Abstract][Full Text] [Related]
19. [Enhancive effect of PLK1 gene silencing on sensitivity of K562/A02 cells to adriamycin].
Liu L; Zhang M; Zou P; Tian L; Liu F
Ai Zheng; 2006 Apr; 25(4):404-8. PubMed ID: 16613670
[TBL] [Abstract][Full Text] [Related]
20. [Orphanin FQ combined with adriamycin reverses multi-drug resistance of K562/ADM and its molecular mechanism].
Wang XX; Liu XQ; Zhang W; Chen X; Zhao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):574-8. PubMed ID: 22739158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]